Search for: "AMGEN INC."
Results 681 - 700
of 707
Sort by Relevance
|
Sort by Date
7 Jun 2007, 7:39 pm
By Sherri Oslick -- On Wednesday, Amgen Inc. of Thousand Oaks, CA announced that it would acquire drug company Alantos Pharmaceuticals of Cambridge, MA for $300 million cash. [read post]
5 Jun 2007, 11:46 am
By Sherri Oslick -- On Monday, Amgen Inc. of Thousand Oaks, CA announced that it would acquire drug company Ilypsa, Inc. of Santa Clara, CA for $420 million cash. [read post]
17 May 2007, 10:20 am
.__) (PDF 697 KB) Introduced by House Financial Services Chairman Barney Frank on May 16, 2007 05/16/2007
Letter to Attorney General Alberto Gonzales from Senate Judiciary Chairman Patrick Leahy and Ranking Member Arlen Specter (PDF 82 KB) Letter requests Gonzales to turn over documents compelled by the Committee as part of a subpoena issued relating to the ongoing investigation 05/16/2007
Letter to Attorney General Alberto Gonzales from Senate Judiciary Chairman Patrick Leahy and… [read post]
15 May 2007, 2:58 pm
Yesterday, Anderson had this article (subscription req'd) in the Wall Street Journal about the Court's rejection of appeals from Amgen Inc. and Neutraceutical Corp. [read post]
15 May 2007, 8:15 am
Medicare on Monday proposed limiting coverage of the anemia medicines that are the backbone of Amgen Inc.'s historically stellar growth, accounting for almost half of the Thousand Oaks (CA) company's sales. [read post]
15 May 2007, 6:59 am
See Amgen Inc. v. [read post]
15 May 2007, 2:39 am
High Court Turns Down Amgen's Appeal in Patent Case
The Associated Press
The Supreme Court on Monday declined to consider a patent dispute between biotech drug maker Amgen Inc. and two other companies involving Amgen's blockbuster anemia drug Epogen. [read post]
14 May 2007, 9:26 pm
**Separately,Mondaq covered the Judge Moore opinion in the inequitable conduct case of eSpeed, Inc. v. [read post]
27 Apr 2007, 12:04 pm
The Need for Independent PTO-Free Post-Grant Governance: The Amgen testimony implied a need for a very reliable post-grant system. [read post]
26 Apr 2007, 2:32 am
BusinessWeek notes another Congressional hearing on patent reform will occur on April 26, with testimony from Kevin Sharer, chief executive of biotech company Amgen Inc.; Anthony Peterman, patent counsel for computer manufacturer Dell Inc.; and Gary Griswold, president and chief counsel of intellectual property at 3M Co.Dell Inc. is a member of the Coalition for Patent Fairness, comprised mainly of IT companies strongly seeking patent reform (including Amazon.com,… [read post]
17 Apr 2007, 8:58 pm
By Sherri Oslick -- In a recent press release, ARIAD Pharmaceuticals, Inc. announced that it has filed suit against Amgen Inc., certain Amgen affiliates, and Wyeth for infringement of U.S. [read post]
17 Apr 2007, 10:46 am
Amgen-Sponsored Study Was Testing Aranesp In Cancer Patients Who Developed Anemia (Posted by Tom Lamb at DrugInjuryWatch.com) An April 17, 2007 Wall Street Journal (WSJ) article about the results of a new study concerning Aranesp revealed more bad news for Amgen Inc., the maker of this anemia drug:Amgen's drug Aranesp didn't reduce the need for blood transfusions in anemic cancer patients and was linked to a nearly 45% increase in deaths compared with patients… [read post]
15 Apr 2007, 2:42 am
Further to discussion about Ariad's US patent 6,410,516, the AP reported on April 13:Ariad Pharmaceuticals Inc. said late Friday [April 13] it filed a counter claim against Amgen Inc. over the patent to methods of treating human disease by regulating NF-(kappa)B cell-signaling activity.The claim _ which is also against drug maker Wyeth _ is a response to a lawsuit filed by Amgen against Ariad, saying the company's claims to the patent are invalid and… [read post]
27 Mar 2007, 3:29 pm
Amgen Inc. has recently filed this new cert. petition in the case of Amgen v. [read post]
23 Mar 2007, 6:54 pm
Today, Amgen has enlisted the aid of... [read post]
23 Mar 2007, 1:30 am
Congressman John Dingel has asked both Johnson & Johnson and Amgen Inc. to stop consumer advertising of their anemia medications for cancer patients until May 2007 or until the FDA wraps up an ongoing review. [read post]
20 Mar 2007, 11:21 am
"Among the companies being sued under for such claims: AstraZeneca, Pfizer Inc., Johnson & Johnson, Amgen Inc., Eli Lilly & Co., GlaxoSmithKline PLC, Bayer Corp. and Hoffman-LaRoche Inc. [read post]
Procrit, Epogen, And Aranesp: New "Black Box" Warnings Only First Part Of FDA's Safety Re-evaluation
12 Mar 2007, 10:10 am
Popular Anemia Drugs Have Increased Risk Of Death, Blood Clots, Strokes, And Heart Attacks, Especially In Context Of Off-label Prescribing And Use (Posted by Tom Lamb at DrugInjuryWatch.com) On March 9, 2007 the FDA announced that Amgen Inc. and Johnson & Johnson (J&J) would add strong new warnings to their anemia drugs Procrit, Epogen, and Aranesp after several recent studies showed a higher risk of death and life-threatening side effects in some patients. [read post]
5 Feb 2007, 10:37 pm
Amgen, Inc., et al. (01/29/2007): appeal of summary judgment to bring patent case for lack of standing (plaintiff did not have sole ownership of the patent), discussion of patent relating to a protein used to treat rheumatoid arthritis (U.S. [read post]
5 Feb 2007, 6:47 pm
A Co-Owner Has a Right to Limit Another Co-Owner's Ability to Sue Infringers by Refusing to Join Voluntarily in a Suit. [read post]
